Histopathological Spectrum of Cutaneous Lymphomas

Article Sidebar

PDF Download
Published Nov 29, 2023
DOI: https://doi.org/10.18103/mra.v11i11.4712

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

A. Kaur Aminder Singh
Department of Pathology, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
A. Singh Harpreet Kaur Bhavna Garg Vikram Narang

Abstract

Background: Cutaneous lymphomas are a heterogeneous group of extra-nodal non-Hodgkin’s lymphomas that are characterized by a cutaneous infiltration of malignant monoclonal lymphocytes. Less frequently, these lymphomas spread from the skin to the blood or a lymph node. The incidence of primary cutaneous lymphoma has been estimated to be 1:100,000 according to the World Health Organization. Usually, these lymphomas affect adults with a median age of 50 to 60 years. T-cell lymphomas predominate over primary B-cell lymphomas of the skin. The most important subtypes of cutaneous T cell lymphomas are Mycosis fungoides, Sezary syndrome, and primary cutaneous peripheral T cell lymphomas not otherwise specified. These subtypes present different clinical, histological, and molecular features, and can follow an indolent or a very aggressive course.


Aim: The aim of this study was to analyze cutaneous lymphomas to ascertain its clinical aspects including prevalence, histopathology and immune profile.


Material and methods: A retrospective analysis of skin biopsies over a 7-year period ranging from 2016 to 2022 was done, of which 11 cases were diagnosed as cutaneous lymphomas. These cases were analyzed in detail including immune profile.


Results & conclusions: The majority of the cases out of all cutaneous lymphomas were of T cell lymphoma and only one case was of B cell type. Definitive diagnosis of CTCL requires a multidisciplinary approach.


Keywords: cutaneous T cell lymphoma, cutaneous B cell lymphoma.

Article Details

How to Cite
KAUR, A. et al. Histopathological Spectrum of Cutaneous Lymphomas. Medical Research Archives, [S.l.], v. 11, n. 11, nov. 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/4712>. Date accessed: 03 dec. 2024. doi: https://doi.org/10.18103/mra.v11i11.4712.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 11 No 11 (2023): November Issue, Vol.11, Issue 11
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019 Apr 18;133(16):1703-1714.
2. Alaggio, R., Amador, C., Anagnostopoulos, I. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36, 1720–1748.
3. Burg G, Dummer R, Kerl H. Classification of cutaneous lymphomas. Dermatologic Clinics. 1994 Apr;12(2):213-217.
4. Bagherani N, Smoller BR. An overview of cutaneous T cell lymphomas. F1000Res. 2016 Jul 28;5: F1000 Faculty Rev-1882.
5. Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. A Bras Dermatol. 2015 Sep-Oct;90(5):687-706.
6. George R, Bhuvana S, Nair S, Lakshmanan J. Clinicopathological profile of cutaneous lymphomas-A 10 year retrospective study from south India. Indian J Cancer 1999; 36:109-19.
7. Doshi BR, Khopkar US. Retrospective study of spectrum of cutaneous lymphoma presenting to dermatology. Indian J Dermatol Venereol Lepprol 2011; 77:512-515.
8. Sidiropoulos KG, Martinez-Escala ME, Yelamos O, et al.: Primary cutaneous T-cell lymphomas: a review. J Clin Pathol. 2015;68(12):1003–10.
9. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85.
10. Nahidi Y, Meibodi NT, Ghazvini K, et al.: Evaluation of the Association Between Epstein-Barr Virus and Mycosis Fungoides. Indian J Dermatol. 2015; 60(3): 321.
11. Gómez Venegas ÁA, Vargas Rubio RD: Unusual involvement in mycosis fungoides: Duodenal papilla. Rev Esp Enferm Dig. 2015.
12. Pousa CM, Nery NS, Mann D, et al.: Granulomatous mycosis fungoides--a diagnostic challenge. An Bras Dermatol. 2015; 90(4): 554–6.
13. Hughes CF, Newland K, McCormack C, et al.: Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers. Australas J Dermatol. 2015.
14. Hope CB, Pincus LB. Primary cutaneous B-cell lymphomas with large cell predominance primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma. Semin Diagn Pathol. 2017;34(1):85-98.
15. Swerdlow SH. Cutaneous marginal zone lymphomas. Semin Diagn Pathol. 2017;34(1): 76-84.
16. Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumours. 4th ed. Lyon, France: IARC Press; 2018.
17. Dobos G, Pohrt A, Ram-Wolff C, Lebbé C, Bouaziz J-D, Battistella M, Bagot M, de Masson A. Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients. Cancers. 2020; 12(10):2921.
18. Abeldano, A.; Enz, P.; Maskin, M.; Cervini, A.B.; Torres, N.; Acosta, A.C.; Narbaitz, M.; Vanzulli, S.; Orentrajch, M.; Villareal, M.A.; et al. Primary cutaneous lymphoma in Argentina: A report of a nationwide study of 416 patients. Int. J. Dermatol. 2019, 58, 449–455.
19. Mourad, A.; Gniadecki, R. Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis. J. Investig. Dermatol. 2020, 140, 495–497. e.5.
20. Clough, L.; Bayakly, A.R.; Ward, K.C.; Khan, M.K.; Chen, S.C.; Lechowicz, M.J.; Flowers, C.R.; Allen, P.B.; Switchenko, J.M. Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia. Cancer 2020, 126, 1700–1707.
21. Hristov AC, Tejasvi T, A. Wilcox R. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk stratification, and management. Am J Hematol. 2021;96(10): 1313-1328.
22. Geller S, Lebowitz E, Pulitzer MP, et al. Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sezary syndrome: retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol. 2020;83: 430-439.
23. Jung JM, Lim DJ, Won CH, Chang SE, Lee MW, Lee WJ. Mycosis Fungoides in children and adolescents: a systematic review. JAMA Dermatol. 2021; 157:431-438.
24. Goyal A, O'Leary D, Goyal K, Patel K, Pearson D, Janakiram M. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer. J Am Acad Dermatol. 2021 Dec;85(6):1418-1428.
25. Jones CL, Degasperi A, Grandi V, et al. Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma. Sci Rep. 2021; 11:3962.
26. Gibbs JD, Ma S, Kim A, et al. Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T cell lymphoma. Oncol Rep. 2021;45:349-358.
27. Dittmer M, Brown-Joel ZO, Smith HL, Liu V. Influence of clinical information on the histopathological diagnosis of mycosis fungoides: a follow-up study using scanned slide image review. J Cutan Pathol. 2021;48:719-720.
28. Lyapichev KA, Bah I, Huen A, et al. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sezary syndrome than quantification of CD26- or CD7- CD4+ T-cells. Cytometry B Clin Cytom. 2021;100:183-191.
29. Hodak E, Sherman S, Papadavid E, et al. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective cutaneous lymphoma international prognostic index (PROCLIPI) international study. Br J Dermatol. 2021;184: 524-531.
30. Pulitzer M. Cutaneous T-cell Lymphoma. Clin Lab Med. 2017 Sep;37(3):527-546.
31. Mirvish JJ, Pomerantz RG, Falo LD Jr, Geskin LJ. Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies. Clin Dermatol. 2013 Jul-Aug;31(4):423-431.
32. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol. 2012 May;36(5):716-25.